Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00075946 Information provided by National Cancer Institute (NCI)

First Received: January 12, 2004 Last Updated: April 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)

Publications:

Kahl BS, Williams ME, Hong F, et al.: Preliminary pharmacokinetic (PK) analysis of Eastern Cooperative Oncology Group Protocol E4402: rituximab extended schedule or re-treatment trial (RESORT) . [Abstract] Blood 110 (11): A-3420, 2007.